Dexcom Inc. (NSDQ:DXCM) shares hovered at the break-even point today after the medical device company announced 3rd-quarter losses greater than analysts on Wall Street expected.
The San Diego-based wireless glucose monitor maker reported losses of $17.3 million, or 25¢ per share, on sales of $23.1 million during the 3 months ended Sept. 30, for a 38.6% top-line gain. Analysts were expected losses of 22¢ per share.